Zevra Therapeutics, Inc.
Zevra Therapeutics, Inc., headquartered in the United States, is a pioneering biopharmaceutical company focused on developing innovative therapies for rare diseases and unmet medical needs. Founded in 2020, Zevra has quickly established itself in the biotechnology industry, particularly in the areas of neurology and rare genetic disorders. The company’s core offerings include unique therapeutic solutions that leverage advanced scientific research and technology, setting them apart in a competitive market. Zevra's commitment to addressing complex health challenges has led to significant milestones, including the advancement of its lead product candidates through various stages of clinical development. With a strong emphasis on patient-centric approaches, Zevra Therapeutics is poised to make a meaningful impact in the lives of those affected by rare conditions.
DitchCarbon Score
How does Zevra Therapeutics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Zevra Therapeutics, Inc.'s score of 13 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Zevra Therapeutics, Inc.'s reported carbon emissions
Zevra Therapeutics, Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without reported emissions figures, it is unclear how their operations impact the environment in terms of greenhouse gas emissions. However, the absence of data does not diminish the importance of climate commitments within the biopharmaceutical industry. Companies in this sector are increasingly recognising the need to address climate change through sustainable practices and initiatives. As Zevra Therapeutics continues to develop its strategies, stakeholders may look for future commitments to reduce carbon footprints and enhance environmental sustainability.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Zevra Therapeutics, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
